Carisma Therapeutics Ownership | Who Owns Carisma Therapeutics?


OverviewForecastRevenueFinancialsChart

Carisma Therapeutics Ownership Summary


Carisma Therapeutics is owned by 13.42% institutional investors, 27.76% insiders, and 58.82% retail investors. Tower research capital llc (trc) is the largest institutional shareholder, holding 0% of CARM shares.

CARM Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockCarisma Therapeutics13.42%27.76%58.82%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Tower research capital llc (trc)---
Barclays---
Baader bank aktiengesellschaft---
Stratos wealth partners---
Millennium management---
Virtu financial---
Lpl financial---
Peoples bank/ks---
Stonex group---
Hrt financial lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tower research capital llc (trc)---
Barclays---
Baader bank aktiengesellschaft---
Stratos wealth partners---
Millennium management---
Virtu financial---
Lpl financial---
Peoples bank/ks---
Stonex group---
Hrt financial lp---

Top Buyers

HolderShares% AssetsChange
Citigroup---10.00
Peoples bank/ks---250.00
Federated hermes---5.63K
Tower research capital llc (trc)---7.83K
Stonex group---10.73K

Top Sellers

HolderShares% AssetsChange
Barclays---549.30K
Millennium management---120.16K
Hrt financial lp---36.90K
Stratos wealth partners---22.20K
Goldman sachs group---21.38K

Sold Out

HolderChange
Citigroup-10.00
Peoples bank/ks-250.00
Federated hermes-5.63K
Tower research capital llc (trc)-7.83K
Stonex group-10.73K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202536-5,576,15716.58%1310.13%14-6.67%6-14.29%
Dec 31, 2024382.70%4,888,967-6.07%117.50%1645.45%7-41.67%
Sep 30, 202437-24.49%5,205,020-14.78%125.80%11-60.71%12-7.69%
Jun 30, 202449-2.00%6,107,691-28.20%143.40%2855.56%13-31.58%
Mar 31, 202450-3.85%8,506,543-5.48%204.19%18-21.74%1946.15%

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

CARM Ownership FAQ


Who Owns Carisma Therapeutics?

Carisma Therapeutics shareholders are primarily institutional investors at 13.42%, followed by 27.76% insiders and 58.82% retail investors. The average institutional ownership in Carisma Therapeutics's industry, Biotech Stocks , is 64.05%, which Carisma Therapeutics falls below.

Who owns the most shares of Carisma Therapeutics?

Carisma Therapeutics’s largest shareholders are Tower research capital llc (trc) (0 shares, 0%), Barclays (0 shares, 0%), and Baader bank aktiengesellschaft (0 shares, 0%). Together, they hold 0% of Carisma Therapeutics’s total shares outstanding.

Does Blackrock own Carisma Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Carisma Therapeutics.

Who is Carisma Therapeutics’s biggest shareholder by percentage of total assets invested?

Tower research capital llc (trc) is Carisma Therapeutics’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Carisma Therapeutics shares, valued at 0$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools